Searched for
CHINESE DRUGMAKER
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...- Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firmsIndia’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...
- Pfizer in diabetes drug deal with Sciwind BiosciencesPfizer has partnered with Sciwind Biosciences for a new type 2 diabetes drug. The deal could be worth up to 495 million dollars. This drug,...
- Cipla in talks to add new customers for its China factory, executive saysIndian pharmaceutical giant Cipla is exploring at least two new overseas markets for products made at its Chinese manufacturing plant, as i...
- Biocon drops plan to launch weight-loss drugs in China, executive saysBiocon has scrapped its plans to introduce generic versions of Novo Nordisk's Ozempic and Wegovy in China, citing intense local competition...
- AstraZeneca to invest $2.5 billion in China research and development hubAstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment to China, its...
- Sanofi to build $1 billion insulin production base in ChinaSanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 million people i...
- WHO sets dates for reviews of Sinopharm and Sinovac COVID-19 vaccinesSo far COVID-19 vaccines made by Pfizer AstraZeneca and Johnson & Johnson have received a WHO listing - an endorsement of their safety and ...
- Chinese drugmaker in talks to test virus vaccine globallyWith China having largely curbed its growth of new infections, its drugmakers will need to seek international cooperation to test their vac...
- Top PE firms join race for Claris Lifesciences’ US businessThe business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...
- Chinese police to brief media on GlaxoSmithKline amid probeThe company has said previously that some of its senior Chinese executives appear to have broken law and it has zero tolerance for bribery.
- GlaxoSmithKline emerging markets head sent to handle China crisis: SourceGlaxoSmithKline has sent its head of emerging markets to China to lead the drugmaker's response to an unfolding crisis over alleged bribery...
- Antibiotics may get costlierThe government may levy duty on two important drug ingredients imported from China and Mexico to protect local suppliers.
- Drugs for exports must carry barcodeThe government has made it mandatory for drugmakers to carry a barcode on every product exported out of the country to put an end to allega...
- Indian, Chinese drug cos may jointly bid for global tendersIndian and Chinese drug manufacturers may jointly bid for global supply tenders as the industry bodies of both the countries are expected t...
- Drug regulator bans raw material import from 10 Chinese firmsThe country’s drug regulator has banned import of raw material from 10 Chinese drug companies for supplying products without having the man...
- Global pharma MNCs find China toughColleen Cheng and Angel Chen, Chinese marketing executives in their 30s, should be the ideal customers for US and European drugmakers.
Load More
